STAMPOUT: Study of Antibody for Methamphetamine Outpatient Therapy.

Trial Profile

STAMPOUT: Study of Antibody for Methamphetamine Outpatient Therapy.

Not yet recruiting
Phase of Trial: Phase I/II

Latest Information Update: 09 Jan 2018

At a glance

  • Drugs IXT-m200 (Primary)
  • Indications Drug abuse
  • Focus Pharmacokinetics; Proof of concept
  • Acronyms STAMPOUT
  • Sponsors InterveXion Therapeutics
  • Most Recent Events

    • 04 Jan 2018 According to an InterveXion Therapeutics media release, the company recently announced full US NIDA funding for this upcoming Phase 2 study which is expected to initiate in 1H18.
    • 06 Nov 2017 Status changed from planning to not yet recruiting.
    • 11 Oct 2017 New trial record
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top